Carson City Dialysis Center (DVA) is a medicare approved dialysis facility center in Carson City, Nevada and it has 24 dialysis stations. It is located in Carson City county at 3246 N Carson St Ste 110, Carson City, NV, 89706. You can reach out to the office of Carson City Dialysis Center (DVA) at (775) 886-6450. This dialysis clinic is managed and/or owned by Davita. Carson City Dialysis Center (DVA) has the following ownership type - Non-Profit. It was first certified by medicare in June, 1997. The medicare id for this facility is 292539 and it accepts patients under medicare ESRD program.
| Name | Carson City Dialysis Center (DVA) |
|---|---|
| Location | 3246 N Carson St Ste 110, Carson City, Nevada |
| No. of Dialysis Stations | 24 |
| Medicare ID | 292539 |
| Managed By | Davita |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 3246 N Carson St Ste 110, Carson City, Nevada, 89706 | |
| (775) 886-6450 | |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
| NPI Number | 1073584322 |
| Organization Name | Renown Health Dialysis |
| Doing Business As | Renown Regional Medical Center |
| Address | 3310 Goni Rd Carson City, Nevada, 89706 |
| Phone Number | (775) 886-6450 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
| NPI Number | 1669612347 |
| Organization Name | Carson City Dialysis Center |
| Doing Business As | Routt Dialysis Llc |
| Address | 3246 N Carson St Carson City, Nevada, 89706 |
| Phone Number | (775) 886-6450 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 43 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 67 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 614 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 13 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 124 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 94 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Carson City Dialysis Center (DVA) with elevated calcium levels.
| Patients with hypercalcemia | 81 |
| Hypercalcemia patient months | 750 |
| Patients with Serumphosphor | 84 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 103 |
| Patient months included in arterial venous fistula and catheter summaries | 502 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 78 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 70 |
| Hospitalization Rate in facility | 409 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 636.3 |
| Hospitalization Rate: Lower Confidence Limit | 272.2 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Carson City Dialysis Center (DVA) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 20.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.3 |
| Readmission Rate: Lower Confidence Limit | 12.6 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Carson City Dialysis Center (DVA) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .66 (As Expected) |
| SIR: Upper Confidence Limit | 1.79 |
| SIR: Lower Confidence Limit | .17 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Carson City Dialysis Center (DVA)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 58 |
| Transfusion Rate in facility | 47.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 164.9 |
| Transfusion Rate: Lower Confidence Limit | 15.8 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Carson City Dialysis Center (DVA) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 324 |
| Mortality Rate in facility | 18.1 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.2 |
| Mortality Rate: Lower Confidence Limit | 13.2 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago
Carson City Dialysis Center (DVA) Location: 3246 N Carson St Ste 110, Carson City, Nevada, 89706 Phone: (775) 886-6450 |
Liberty Dialysis - Carson City Location: 4500 S Carson St, Carson City, Nevada, 89701 Phone: (775) 461-7250 |
News Archive
InterSystems Corporation, the global leader in software for connected health care, today announced that the IT productivity bar has been raised by the University of California Davis Health System with its rollout of the InterSystems Ensemble rapid integration and development platform. The announcement highlighting the UC Davis achievements came during the HIMSS11 conference.
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
MorNuCo Laboratories of West Lafayette, Indiana, and their ONCOblot Test recently completed a retrospective clinical trial focusing on the early detection of malignant mesothelioma, with the exciting results that the ONCOblot test detected a molecular marker that is indicative of the presence of mesothelioma, 4-10 years in advance of clinical symptoms appearing.
› Verified 5 days ago